Multimodal Assesment of Alzheimer Patients

Recruiting now

Conditions studied: Mild Cognitive Impairment, Alzheimer Disease, Late Onset, Cognitive Impairment, Dementia

In brief

The goal of this study is to learn more about the changes in the brains of patients with cognitive impairment (MCI) and Alzheimer's Disease (AD). The main questions the study aims to answer are: 1. What findings can be used to earlier detect patients that will develop Alzheimers? 2. Which differences are seen between healthy and cognitively impaired patients? 3. Which differences are seen between patients with Alzheimers disease? Participants will undergo: * Cognitive tests * Magnetic resonance imaging (MRI) * Electroencephalography (EEG) * Blood sample collection * Fecal sample collection * A randomized group will undergo polysomnography analysis.

Key facts

Study ID

NCT06448403

Run by

Norwegian University of Science and Technology

People needed

60

Starts

2024-07-01

Expected to finish

2030-12-29

Last updated by the study team

2025-08-07

Who can join

Age: 65 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• MCI and AD according to relevant ICD-criterias.
• Control cohort is age and gender matched with other cohorts.

You may not qualify if…

• Uneligibility for any of the planned neuroimagery devices (MRI, EEG)
• AD diagnosis before the age of 65 (Early-onset AD).
• Brain tumor
• Traumtic head injury
• Earlier neurosurgery
• Other neyrodegenerative diseases (i.e Parkinson and ALS)
• Diseases related to inflammation and auto-immunity (i.e MS)

Where it is running

• Norwegian University of Sciene and Technology / Norges teknisk-naturvitenskapelige universitet (NTNU) — Trondheim, Trønderlag, Norway (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.